Reference
- ANDREESEN, R, Barr, J., and L5HR, G. W., 1983, Primary cultures of human blood-bone macrophages grown on hydrophobic Teflon membranes. Journal of Immunological Methods, 56, 295–304.
- BENDER, A, SCHAFER, V., STEFFAN A M., ROYER, C, KREUTER, J., RiinSAmENWAIGmANN H., and VON BRIESEN H., 1994, Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles. Research in Virology, 145, 215–220.
- BENDER, A, VON BRIESEN H., KREUTER, J., DUNCAN I. B., and RiASAMEN-WAIGMANN H., 1996, Efficiency of nanoparticles as a carrier system for antiviral agents in human monocytes/macrophages in vitro. Antimicrobial Agents and Chemotherapy, 40, 1467–1471.
- HASSIg A, and STAMPFLI, K, 1969, Plasma substitutes past and present Bibliotheca Haematologica, 33, 1–8.
- MARTY, J. J., OPPENHEIM R C, and SPEISER, P., 1978, Nanoparticles—a new colloidal drug delivery system. Pharma Acta Helveticae, 53, 17–23.
- ORENSTEIN J. M., FM, C, and WAHL, S. M., 1997, Macrophages as a source of HIV during oportunistic infections. Science, 276, 1857–1861.
- SCHAPER, V., KREUTER, J., RiASAMEN-WAIGMANN H., GERTE, S., and vav BuEsEN, H., 1994, Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes. Clinical and Diagnostic Virology, 1, 279–287.
- SCHAFER, V., VON BRIESEN H., ANDREESEN R, STEAN A. M., ROYER, C, TRöSTER, S., KREUTER, J., and RiASAMEN-WAIGMANN H., 1992, Phagocytosis of nanoparticles by HIV-infected macrophages: a possibility for antiviral drug-targeting. Pharmaceu-tical Research, 9, 541–546.
- SCHWICK, H. G., and HEIDE, K, 1969, Immunochemistry and immunology of collagen and gelatin [Review]. Bibliotheca Haematologica, 3, 111–125.